An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life

Alicia Jenkins, Balasubramanium Krishnamurthy, James Best, Fergus Cameron, Peter Colman, Peter Hamblin, Michele O'Connell, Christine P Rodda, Helena Teede, David O'Neal

Research output: Contribution to journalArticleResearchpeer-review

Abstract

This study evaluated the impact on quality of life (QoL) of an algorithm guiding the responses of continuous subcutaneous insulin infusion (CSII) treated type 1 diabetes (T1D) patients using real-time (RT) continuous glucose monitoring (CGM).
Original languageEnglish
Pages (from-to)105 - 109
Number of pages5
JournalDiabetes Technology and Therapeutics
Volume13
Issue number2
DOIs
Publication statusPublished - 2011

Cite this

Jenkins, A., Krishnamurthy, B., Best, J., Cameron, F., Colman, P., Hamblin, P., ... O'Neal, D. (2011). An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. Diabetes Technology and Therapeutics, 13(2), 105 - 109. https://doi.org/10.1089/dia.2010.0139
Jenkins, Alicia ; Krishnamurthy, Balasubramanium ; Best, James ; Cameron, Fergus ; Colman, Peter ; Hamblin, Peter ; O'Connell, Michele ; Rodda, Christine P ; Teede, Helena ; O'Neal, David. / An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. In: Diabetes Technology and Therapeutics. 2011 ; Vol. 13, No. 2. pp. 105 - 109.
@article{c354bb04d07444e2bfc73e1f6f35eb94,
title = "An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life",
abstract = "This study evaluated the impact on quality of life (QoL) of an algorithm guiding the responses of continuous subcutaneous insulin infusion (CSII) treated type 1 diabetes (T1D) patients using real-time (RT) continuous glucose monitoring (CGM).",
author = "Alicia Jenkins and Balasubramanium Krishnamurthy and James Best and Fergus Cameron and Peter Colman and Peter Hamblin and Michele O'Connell and Rodda, {Christine P} and Helena Teede and David O'Neal",
year = "2011",
doi = "10.1089/dia.2010.0139",
language = "English",
volume = "13",
pages = "105 -- 109",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc",
number = "2",

}

Jenkins, A, Krishnamurthy, B, Best, J, Cameron, F, Colman, P, Hamblin, P, O'Connell, M, Rodda, CP, Teede, H & O'Neal, D 2011, 'An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life' Diabetes Technology and Therapeutics, vol. 13, no. 2, pp. 105 - 109. https://doi.org/10.1089/dia.2010.0139

An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. / Jenkins, Alicia; Krishnamurthy, Balasubramanium; Best, James; Cameron, Fergus; Colman, Peter; Hamblin, Peter; O'Connell, Michele; Rodda, Christine P; Teede, Helena; O'Neal, David.

In: Diabetes Technology and Therapeutics, Vol. 13, No. 2, 2011, p. 105 - 109.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life

AU - Jenkins, Alicia

AU - Krishnamurthy, Balasubramanium

AU - Best, James

AU - Cameron, Fergus

AU - Colman, Peter

AU - Hamblin, Peter

AU - O'Connell, Michele

AU - Rodda, Christine P

AU - Teede, Helena

AU - O'Neal, David

PY - 2011

Y1 - 2011

N2 - This study evaluated the impact on quality of life (QoL) of an algorithm guiding the responses of continuous subcutaneous insulin infusion (CSII) treated type 1 diabetes (T1D) patients using real-time (RT) continuous glucose monitoring (CGM).

AB - This study evaluated the impact on quality of life (QoL) of an algorithm guiding the responses of continuous subcutaneous insulin infusion (CSII) treated type 1 diabetes (T1D) patients using real-time (RT) continuous glucose monitoring (CGM).

UR - http://online.liebertpub.com/doi/pdf/10.1089/dia.2010.0139

U2 - 10.1089/dia.2010.0139

DO - 10.1089/dia.2010.0139

M3 - Article

VL - 13

SP - 105

EP - 109

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 2

ER -